
Sign up to save your podcasts
Or


Berkeley biochemist Jennifer Doudna joins oncologist Siddartha Mukherjee to discuss unprecedented advancements in gene editing and the effect new technologies will have on the future of humanity.
Dr. Doudna’s research has led to what is being called the biggest scientific discovery of our era: the development of the genetic editing tool, CRISPR-Cas9. This revolutionary technology has quickly transformed the landscape of genome engineering, creating limitless possibilities for impact within biomedicine, agriculture, climate and energy, and more, including treating — and possibly curing — genetic diseases.
Dr. Mukherjee is a celebrated physician and researcher. His book, The Emperor of All Maladies: A Biography of Cancer, won the Pulitzer Prize for nonfiction in 2011, was named one of the 100 most influential books written in English since 1923 by TIME magazine, and was listed as one of the 100 notable books of 2010 by the New York Times magazine.
This conversation, which took place on Jan. 18, 2018, was sponsored by the Innovative Genomics Institute.
Listen and read the transcript on Berkeley News.
Hosted on Acast. See acast.com/privacy for more information.
By UC Berkeley4.8
2525 ratings
Berkeley biochemist Jennifer Doudna joins oncologist Siddartha Mukherjee to discuss unprecedented advancements in gene editing and the effect new technologies will have on the future of humanity.
Dr. Doudna’s research has led to what is being called the biggest scientific discovery of our era: the development of the genetic editing tool, CRISPR-Cas9. This revolutionary technology has quickly transformed the landscape of genome engineering, creating limitless possibilities for impact within biomedicine, agriculture, climate and energy, and more, including treating — and possibly curing — genetic diseases.
Dr. Mukherjee is a celebrated physician and researcher. His book, The Emperor of All Maladies: A Biography of Cancer, won the Pulitzer Prize for nonfiction in 2011, was named one of the 100 most influential books written in English since 1923 by TIME magazine, and was listed as one of the 100 notable books of 2010 by the New York Times magazine.
This conversation, which took place on Jan. 18, 2018, was sponsored by the Innovative Genomics Institute.
Listen and read the transcript on Berkeley News.
Hosted on Acast. See acast.com/privacy for more information.

90,966 Listeners

38,518 Listeners

6,782 Listeners

9,193 Listeners

4,052 Listeners

433 Listeners

112,031 Listeners

32,330 Listeners

190 Listeners

20 Listeners

3,734 Listeners

7,227 Listeners

15,852 Listeners

1,579 Listeners

3,539 Listeners

5,903 Listeners